The FDA has approved Tirzepatide under the name Mounjaro for treating diabetes, but the utility of reducing excess body weight gained more attention
stacking Dihexa with cholinergic enhancers is theoretically appealing: Examples: Alpha-GPC, CDP-choline, or acetylcholinesterase inhibitors (ACh-E inhibitors) Rationale: Dihexa enhances synaptic plasticity
Alternatives to Mounjaro include: Other GLP-1 agonists , such as Ozempic (semaglutide), Wegovy (semaglutide), Rybelsus (semaglutide), Trulicity (dulaglutide), Victoza (liraglutide), and Saxenda (liraglutide) DPP-4 Inhibitors , such as Januvia (sitagliptin), Onglyza (saxagliptin), and Tradjenta (linagliptin) SGLT2 Inhibitors , such as Invokana (canagliflozin) and Jardiance (empagliflozin) Biguanides , such as Glucophage (metformin) Sulfonylureas , such as Glucotrol (glipizide), Diabeta (glyburide), and Amaryl (glimepiride) Thiazolidinediones , such as Actos (pioglitazone) and Avandia (rosiglitazone) Generic versions of these drugs could help save on costs
The rectal suppository is a solid dosage form that is inserted into the rectum, where it dissolves or melts at body temperature